India NCLT Insolvency Resolution Filings — September 10, 2026

Acquired NCR Rail at an enterprise value of ~₹509.41 Crore (including land), representing a 0.23x price-to-book multiple given negative net worth of ₹2,168.69 Crore, with revenue growing 29.7% from FY2024 to FY2026 (₹8.63 Cr to ₹11.19 Cr)

Resolution plan approved at ₹7.00 Crore for a company with negative net worth of ₹5.31 Crore, implying a 2.32x recovery on book value, but existing shareholders diluted to 5% stake [BEARISH for existing shareholders]

Step-down subsidiary Khurja Rail Terminal Private Limited executed the acquisition, indicating JSW's strategy to build rail connectivity assets for its port-to-rail logistics chain

Subsidiary FTF Pharma admitted to CIRP over a relatively small operational debt of ₹2.18 Crore, suggesting potential deeper financial stress or working capital mismanagement

Court-convened meeting for demerger scheme initially lacked 75% quorum, indicating potential shareholder apathy or opposition to the restructuring plan [NEUTRAL/BEARISH]

Company had zero fixed assets and operated from a rented factory in Hosur, making the resolution plan purely a financial restructuring with no operational turnaround

NCR Rail reported PAT loss of ₹25.96 Crore in FY2026, with accumulated losses of ₹2,168.69 Crore, requiring significant capital infusion for turnaround

IRP appointed is Mr. Sunil Kumar Kedia, a seasoned professional, but the financial impact on the parent company remains unascertainable

Remote e-voting was open from September 6-9, 2026, and results due within two working days, creating near-term uncertainty

Additional land purchase of ~39.57 acres from Arshiya Limited for ₹41.94 Crore (₹1.06 Crore/acre) provides strategic real estate value beyond the rail asset

Existing public shareholders face near-total dilution to 5% stake, with no fixed assets to recover value, representing a complete loss of investment for pre-CIRP shareholders

The NCLT admission of FTF Pharma under Section 9 IBC could trigger cross-default clauses in Shilpa Medicare's debt covenants, potentially impacting the parent's credit profile

Acquiring a company with negative net worth of ₹2,168.69 Crore and annual losses of ₹25.96 Crore requires significant management bandwidth and capital allocation, with no guarantee of operational turnaround

The initial lack of 75% quorum in the court-convened meeting signals potential shareholder dissent or lack of engagement, which could delay or derail the demerger scheme

The company had no fixed assets and operated on a rental basis, raising questions about the resolution applicant's ability to revive operations without asset backing

The company stated the financial impact is 'not yet ascertainable', indicating potential material adverse effects that are being assessed

Despite 29.7% revenue growth over two years, NCR Rail's FY2026 revenue of ₹11.19 Crore is minuscule relative to the ₹467.47 Crore acquisition cost, implying a 41.8x revenue multiple

The meeting adjourned for 30 minutes to meet quorum requirements, suggesting potential legal challenges to the scheme's validity

Acquisition of NCR Rail positions JSW to capture India's growing rail freight demand, with the company's port-to-rail integration strategy potentially unlocking significant cost synergies

The consortium of NG Organics and Nitinbhai Patel acquired 95% control for ₹7.00 Crore, potentially gaining a listed shell company with minimal liabilities [OPPORTUNITY for the acquirer]

The additional 39.57 acres purchased at ₹1.06 Crore/acre in a rail-adjacent location could appreciate significantly as industrial corridors develop around the Dedicated Freight Corridor

The company is evaluating legal options, and successful challenge of the NCLT order could reverse the CIRP admission, creating a positive catalyst

If approved, the demerger of Sammaan Finserve's NBFC undertaking could unlock shareholder value through focused business structures and potential tax efficiencies

NCR Rail's rail infrastructure assets could integrate with JSW's existing port operations at Jaigarh and Paradip, creating an integrated logistics network

The resolution plan provides a clean slate with all existing liabilities extinguished, allowing the new promoters to restart operations without legacy debt burden

With results due within two working days, investors could position for the demerger outcome, though quorum issues add uncertainty

JSW Infrastructure's acquisition of NCR Rail at ₹467.47 Crore demonstrates how infrastructure players are using IBC as a growth tool, paying premium valuations for distressed assets with strategic fit

VXL Instruments' case reinforces the pattern that existing shareholders in CIRP companies face near-total dilution, with only 5% stake retention, highlighting the risk-reward profile of investing in distressed companies pre-CIRP

Shilpa Medicare's subsidiary entering CIRP over a ₹2.18 Crore debt shows how operational defaults can cascade through corporate structures, particularly in capital-intensive sectors like pharmaceuticals

Sammaan Capital's quorum issues in the court-convened meeting highlight the procedural hurdles in NCLT-approved schemes, with potential delays impacting shareholder value realization

VXL Instruments (zero fixed assets) vs JSW Infrastructure (rail infrastructure) shows the spectrum of IBC outcomes, with asset-heavy resolutions offering more tangible recovery potential

JSW's acquisition of NCR Rail and additional land parcels signals growing corporate interest in rail connectivity assets, driven by the government's National Rail Plan and Dedicated Freight Corridor development

Results due within two working days (by September 12, 2026), will determine the fate of the NBFC demerger scheme

The company's evaluation of legal options against the NCLT order, with potential appeal to NCLAT, could reverse the CIRP admission

Monitor operational metrics over next 2-4 quarters for revenue growth and cost synergies from the rail asset acquisition

Resolution plan effective September 9, 2026, watch for the new promoters' business plan and potential revival strategy

Monitor IRP's progress and potential resolution plans for FTF Pharma, which could impact Shilpa Medicare's consolidated financials

Post-vote, the scheme will require NCLT sanction, with the next hearing date critical for timeline clarity

The ₹41.94 Crore land purchase from Arshiya Limited (which is also under stress) could lead to further asset acquisitions from the same counterparty